Camizestrant | CAS 2222844-89-3 - Request Quote
Camizestrant
| SZ CAT No: | SZ-C276001 |
| CAS No | 2222844-89-3 |
| Mol.F. | C24H28F4N6 |
| Mol.Wt. |
476.5 |
| Inv. Status |
Synthesis on demand |
| Rel. CAS No | 2922280-73-5 (TFA salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Hazard Statement:
Usage Note:
Camizestrant is chemically N-(1-(3-Fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine. Camizestrant is supplied with detailed characterization data compliant with regulatory guideline. Camizestrant can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Camizestrant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2222844-89-3
Purchase 2222844-89-3
Order 2222844-89-3
Enquire 2222844-89-3
price of 2222844-89-3
2222844-89-3 Supplier
2222844-89-3 Manufacturer
2222844-89-3 Exporter
buy high quality Camizestrant
Purchase Camizestrant
Camizestrant suppliers
Camizestrant manufacturers
Camizestrant price
Order Camizestrant
Enquire Camizestrant
Camizestrant cost
Camizestrant Supplier
Camizestrant Distributor
Camizestrant for Method Validation
Camizestrant Reference Standard
Camizestrant for ANDA Filing
Camizestrant for Forced Degradation Studies
Camizestrant Identification Standards
Camizestrant for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.